Share-Based Payment Arrangements (Tables)

9 Months Ended

Sep. 28, 2024

Amounts Recognized in Financial Statements with Respect to Plans

Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):

	Thirty-Nine Weeks Ended						Thirteen Weeks Ended
	September 28, 2024			September 30, 2023			September 28, 2024			September 30, 2023
Total cost of the Plans during the period	$	3,573		$	4,270		$	(43	)	$	1,144
Amount of related income tax benefit recognized during the period		(1,997	)		(3,878	)		(313	)		(286	)
Net cost of the Plans during the period	$	1,576		$	392		$	(356	)	$	858

Schedule of Information on Restricted Stock Units

The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:

	Number of			Weighted Average Grant Date
	RSUs			Fair Value
Outstanding at December 30, 2023		132,722		$	138.93
Granted		102,762		$	138.85
Shares earned in excess of target (1)		1,791		$	51.42
Vested shares		(45,057	)	$	115.69
Forfeited		(29,801	)	$	140.20
Outstanding at September 28, 2024		162,417		$	144.13

(1) Represents additional shares earned under the April 24, 2018 and July 1, 2019 RSU awards as total shareholder return during the applicable performance period exceeded target performance level under each of those awards.

Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units

The following table summarizes information regarding the Company’s outstanding shares of non-vested restricted stock and Deferred Stock Units (defined below) under the Plans:

	Number of Shares and Deferred Stock Units			Weighted Average Grant Date Fair Value
Non-vested at December 30, 2023		46,348		$	158.38
Granted		31,525		$	187.08
Vested		(25,647	)	$	151.16
Forfeited		(4,707	)	$	169.92
Non-vested at September 28, 2024		47,519		$	180.17